跳至主要内容
临床试验/NCT03742284
NCT03742284Unknown不适用

Pilot Study to Document Safety and Performance of SoftOx Wound Irrigation Solution in Patients With Split Skin Wounds (Donor Site) Undergoing Skin Transplantation. A Human Model for Acute Trauma Wounds

SoftOx Solutions AS2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2018年11月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
12
试验地点
2
主要终点
- The incidence and severity of any adverse events associated with the SoftOx Wound Irrigation Solution

研究概览

简要总结

This pilot study evaluates safety and performance of the Medical device, SoftOx Wound Irrigation Solution (SWIS), in a model for acute wounds.

详细描述

This is a pilot study with an open-label, exploratory study design with the aim to document preliminary safety and performance of the SoftOx Wound Irrigation Solution while used as intended by the manufacturer, i.e. as an irrigation solution for mechanical rinsing of breached or compromised skin as a result from acute wounds. This first-in-man study will give valuable information on the feasibility of the treatment with the SoftOx Wound Irrigation Solution to prepare for continuous studies in clinically significant settings prior CE marking. The investigation population will consist of 12 subjects undergoing split skin graft transplantation for treating chronic leg ulcers and that are fulfilling the eligibility criteria for the clinical investigation. The SoftOx Wound Irrigation Solution will be applied on the donor site of the split skin graft which is a representative model of acute wounds in a controlled setting. All subjects will be followed up for 21 days. The duration of the investigation is estimated to 4 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 and older
  • Non-healing, leg ulcers, that are scheduled for an operation with excision of the chronic leg ulcer and split skin transplantation
  • Been informed of the nature, the scope and the relevance of the clinical investigation
  • Voluntarily agreed to participation and has duly signed the Informed Consent Form

排除标准

  • Participating in any other clinical investigation
  • On systemic immunomodulating drugs
  • On systemic steroid treatment up to four (4) weeks prior to study inclusion
  • On strong pain medication (e.g. opioids)
  • Severe neuropathy (or dysesthesia on the donor site)
  • Allergy to polyurethane foam, hypochlorous acid, acetic acid or any other remedies/material used in the clinical investigation
  • Not able to read or understand Danish
  • Any other conditions that as judged by the investigator may make follow-up or investigation inappropriate
  • That according to the Declaration of Helsinki is deemed unsuitable for study enrolment

研究组 & 干预措施

SoftOx Wound Irrigation Solution

Other

SoftOx Wound Irrigation Solution is Medical Device that will be applied to rinse acute wounds.

干预措施: SoftOx Wound Irrigation Solution (Device)

结局指标

主要结局

- The incidence and severity of any adverse events associated with the SoftOx Wound Irrigation Solution

时间窗: Evaluation over 21 days

Incidence and severity of any adverse events related to the SoftOx Wound Irrigation Solution will be summarized in terms of frequencies (n), percentages (%) and the mode.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验